𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

✍ Scribed by O'Farrell, A.-M.

Book ID
124066598
Publisher
American Society of Hematology
Year
2003
Tongue
English
Weight
405 KB
Volume
101
Category
Article
ISSN
0006-4971

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

YN968D1 is a novel and selective inhibit
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang LΓΌ; Yongping Xu; Jin πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 527 KB

Angiogenesis is an important process in cell development, especially in cancer. Vascular endothelial growth factor (VEGF) signaling is an important regulator of angiogenesis. Several therapies that act against VEGF signal transduction have been developed, including YN968D1, which is a potent inhibit